As the quest for vaccines continues, experimental coronavirus treatment remdesivir has failed in its first randomised clinical trial
Results of the trial were released on Thursday, April 23, dashing all hopes
The deadly disease was first recorded in China in December 2019
The experimental coronavirus treatment remdesivir has failed in its first randomised clinical trial.
Results of the trial were released on Thursday, April 23, Manila Bulletin reports.
According to a draft summary that went online briefly on the website of the World Health Organization (WHO), the Chinese trial involved 237 patients, with 158 on the drug and 79 in a control group. Remdesivir was stopped early in 18 patients because of side effects.
After three months, 13.9 percent of the patients on remdesivir had succumbed to the deadly disease compared to 12.8 percent of those in the control group. The difference is not statistically significant.
The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.
Thanks for Reading via the most updated news portal
Get us on Whatsapp: +234(0)8181166425
Email Us: email@example.com
SUPPORT LEAKBLAST JOURNALISM OF INTEGRITY AND CREDIBILITY
Good journalism costs a lot of money.
For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble Endeavor.
By contributing to LeakBlast, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.